rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1999-12-10
|
pubmed:abstractText |
Autogenous chondrocyte transplantation (ACT) is a promising but disputable new method for the treatment of full thickness hyaline cartilage defects. Neither long-term follow-up studies nor prospective randomised comparative clinical trials exist to measure the outcome.
|
pubmed:language |
ger
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0044-3220
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
137
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
386-92
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10549113-Aggrecans,
pubmed-meshheading:10549113-Cartilage, Articular,
pubmed-meshheading:10549113-Cell Count,
pubmed-meshheading:10549113-Cell Survival,
pubmed-meshheading:10549113-Chondrocytes,
pubmed-meshheading:10549113-Collagen,
pubmed-meshheading:10549113-Culture Media, Conditioned,
pubmed-meshheading:10549113-Extracellular Matrix Proteins,
pubmed-meshheading:10549113-Humans,
pubmed-meshheading:10549113-Lectins, C-Type,
pubmed-meshheading:10549113-Proteoglycans,
pubmed-meshheading:10549113-Quality Assurance, Health Care,
pubmed-meshheading:10549113-Transplantation, Autologous
|
pubmed:articleTitle |
[Current status of autologous chondrocyte transplantation].
|
pubmed:affiliation |
Abteilung Orthopädie I, Orthopädische Universitätsklinik Heidelberg.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract,
Review
|